News
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.
COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...
Prayagraj: World Doctors' Day will be observed on Tuesday, July 1, under the theme ‘Behind the Mask, Who Heals the Healers' - a reflection on the ment.
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...
Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...
20d
Stars Insider on MSNWhat is chronic obstructive pulmonary disease?According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.3 million deaths in 2019. In 2020, 148,512 ...
13d
News-Medical.Net on MSNDigital inhalers show promise in predicting COPD flare-upsDigital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...
Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...
Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results